LIVESTRONG Survivorship Care Plan: Continued Data Collection and Follow Up Survey

Cancer Patient Clinical Trial

Official title:

LIVESTRONG Survivorship Care Plan: Continued Data Collection and Follow Up Survey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02559323
• Other study ID #: UPCC 04910
• Status: Completed
• Start date: May 2010
• Est. completion date: July 2016

Study information

• Verified date: July 2022
• Source: Abramson Cancer Center of the University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Cancer survivors face unique health challenges as a result of their cancer diagnosis and treatment. OncoLink created an Internet based program for survivors to learn about their risks. A follow up survey will allow us to continue to develop the program in ways that will benefit users. This survey will need to be conducted via email, which will require the collection of the users email address and a secure method of linking the users care plan questionnaire answers to their survey answers.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2000
• Est. completion date: July 2016
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Diagnosis of cancer

• 18 years of age and older

Exclusion Criteria:

• Persons who have never had cancer. This program is designed for survivors of adult cancers.

• Survivors of childhood cancers are referred to the Children's Oncology Group Long Term Follow up Guidelines.

Related Conditions & MeSH terms

• Cancer Patient

Intervention

Other:
• Survey

Locations

Country	Name	City	State
United States	Abramson Cancer Center of the University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Abramson Cancer Center of the University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of subjects completing questionnaires		2 years